RxDoctor Payments Data

Joel Brunson

Family · Jackson, TNNPI 1043519705

Payments from drug & device makers

$2,281in general payments, 2019–2025

Across 162 payments — averaging $14.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$360
  • Novo Nordisk$330
  • AbbVie$302
  • Biohaven Pharmaceuticals, Inc.$182
  • Johnson & Johnson$168
  • Boehringer Ingelheim$158
  • plus $782 from 13 others

What the payments were for

  • Food & beverage$2,281100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,281 in reported general payments places this provider in the 75th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$129,712
Medicare patients
490
Services billed
4,848

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide39$60,482
EliquisApixaban46$36,971
JardianceEmpagliflozin33$36,333
JanuviaSitagliptin Phosphate16$20,821
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$20,083
FarxigaDapagliflozin Propanediol16$13,970
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$10,727
Dapagliflozin-Metformin ErDapaglifloz Propaned/Metformin11$5,993
Gabapentin210$3,158
Atorvastatin Calcium243$2,824
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen113$1,667
Losartan Potassium139$1,519
Nebivolol Hcl18$1,439
Duloxetine Hcl54$1,375
Metoprolol Succinate76$1,338

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$330$60,48239 claims
PfizerEliquis$112$36,97146 claims
Boehringer IngelheimJardiance$158$36,33333 claims
AstraZenecaFarxiga, Breztri Aerosphere$49$24,69727 claims
GSKTrelegy Ellipta$63$20,08314 claims
AbbVieSynthroid$302$1,19223 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 6,706 family providers in Tennessee.

Other family in Jackson

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →